Wheeler Bio, Inc.

2024 was quite a year! I have been at Wheeler Bio, Inc. for approximately ninety days and it feels like I joined the team yesterday. I am extremely impressed with the Wheeler team and their passion for science and for collaborating with innovative partners throughout the biopharmaceutical industry. Wheeler has completed a significant amount of foundational scientific work that supports our Modular CMC approach that enables rapid transition from gene to stable pools to delivering toxicology material and, in parallel, clone selection, to master and working cell banks to cGMP release of Phase 1 product. We are eager to partner with innovative biotechnology companies to rapidly advance antibody-based therapies beginning from a gene or if you have an immediate need for clinical manufacturing, we can support your program. Our team and capabilities are strong and expanding. To experience a "drones eye view" of our capabilities please enjoy this video. https://lnkd.in/eek8yfcB We look forward to expanding our capabilities, partner and investor base in 2025! Wheelerbio.com

More open positions are now available! Follow the link below to see all of the new career opportunities at Wheeler Bio, Inc. including positions in: ▶️ Analytical Development ▶️ GMP Manufacturing ▶️ Project Managment ▶️ Business Development Come join the Wheeler Team and be part of the new #CDMO paradigm! #hiring #analytical #development #gmp #manufacturing #PMO #BD

I'm looking forward to attending Biotech Showcase 2025! Join me in San Francisco, January 13–15, 2025 https://lnkd.in/gj4b4vS5 #BiotechShowcase Informa Connect

The whole Wheeler Bio, Inc. family would like to wish everyone a happy holiday season! We hope that you all can take this time to turn your attention to those that matter most in your lives and enjoy the end of 2024 with family and friends. As the team winds down in preparation for the new year, we also want to sincerely thank all of our investors, clients, partners, and supporters throughout the industry for making 2024 such a transformative year for Wheeler. Your support has set us up for continued success and allows us to relentlessly pursue our mission of serving patients in need. See you in 2025!

Wheeler Bio, Inc. will be attending JP Morgan 2025! Our CEO, Patrick Lucy, and CCO, Sheli Streck, will be in San Francisco Jan. 13-16 to attend the 43rd Annual JPM Healthcare Conference to tell the Wheeler story and share our vision for the new year. After a transformative 2024, we can't wait to share our latest advancements, reconnect with our old colleagues, and make new friends as we all come together to solve today's most pressing health challenges. Follow the link below to reach out and schedule a meeting with us! ▶️ wheelerbio.com/contact/ #JPM2025 #Healthcare #Biotech #Therapeutics #Conference

Next week, the Wheeler Bio, Inc. team will be attending Antibody Engineering & Therapeutics 2024 in San Diego! Reach out to Aaron Pilling, PhD or Ken Meek to schedule a meeting and learn more about our modular, client-focused approach to CMC development and clinical manufacturing. Also, don't miss Aaron's talk on Wednesday at 12pm PT to get the latest updates on Wheeler's expansion in capabilities to further accelerate clinical progression for biologics innovators. See you there! #GMP #CMC #Discovery #Biologics #Antibody

𝗖𝗼𝗺𝗲 𝗷𝗼𝗶𝗻 𝘁𝗵𝗲 𝗪𝗵𝗲𝗲𝗹𝗲𝗿 𝘁𝗲𝗮𝗺! Wheeler Bio, Inc. is seeking to expand our team with highly motivated individuals who want to change the biologics CDMO industry in favor of innovators for the benefit of patients in need! ⬇️ See all open positions and apply below ⬇️

In just two weeks, Wheeler Bio, Inc.'s own Aaron Pilling, PhD will be delivering an exciting talk at this year's Antibody Engineering & Therapeutics conference in beautiful San Diego! Make sure to attend to learn more about Wheeler's unique #CDMO offerings, our cutting-edge #antibody #CMC development and manufacturing capabilities, and our near-term expansion in capabilities to serve our growing demand and client needs. Follow the link below to schedule some time with our team. We can't wait to see you all at AE&T 2024! wheelerbio.com/contact

Peanut butter and jelly. Batman and Robin. Wheeler’s Portable CMC® and ATUM's miFuc™. Did you hear? These powerhouse platforms are teaming up for improved cell line development! Wheeler Bio, Inc. recently announced an expansion in capabilities through the licensing of ATUM’s innovative miFuc platform designed for expression of recombinant proteins containing afucosylated glycans. Read more about this exciting agreement ➡️ https://hubs.li/Q02XTgCv0

We at Wheeler Bio, Inc. want to take today to express our gratitude to all of America's veterans whose sacrifice, commitment and dedication to our country have afforded us the opportunities and freedoms we enjoy every day. To all those who have served or are actively serving, we hope to honor your sacrifice by using these freedoms to work toward a brighter future for the United States. To all of our veterans and their families, thank you for your service!